company logo

Business Analyst at Seagen Inc in Bothell, WA

Seagen Inc
clockMore than 4w ago
bookmark emptySave
More info when clicked here
You fill 1 form 1 time and we do your job applications through Apply4Me.
What's Apply4Me?

compensation:

$80K — $100K *

specialty:

Business Analysis

experience:

5 - 7 years

Job Description

See More arrow

Valid through: 1/24/2022

About Seagen Inc

Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington, is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. Antibody-drug Conjugates are intended to spare non-targeted cells and thus reduce many of the toxic effects of traditional chemotherapy, while potentially enhancing antitumor activity.

The company's flagship product Adcetris is commercially available for four indications in more than 65 countries, including the U.S., Canada, Japan and members of the European Union.

To expand on the clinical opportunities of brentuximab vedotin, Seattle Genetics is conducting a broad clinical development program

to evaluate its therapeutic potential in earlier lines of its approved indications as well as in a range of other lymphoma and non-lymphoma settings. The company is jointly developing brentuximab vedotin in collaboration with Takeda Pharmaceutical Company. Under the terms of the collaboration, Seattle Genetics has full commercialization rights to brentuximab vedotin in the United States and Canada. Takeda has exclusive rights to commercialize the product candidate in all other countries.

In addition to brentuximab vedotin, Seattle Genetics' product pipeline includes enfortumab vedotin, being co-developed with Astellas Pharma, tisotumab vedotin, being co-developed with Genmab, SGN-LIV1A, an ADC targeting LIV-1, and several immuno-oncology agents in phase 1 studies.
stats icon
Total Jobs:
100
stats icon
Total Experts:
4
stats icon
Average Pay:
$136,525
stats icon
Total value of jobs:
$240,285,000
stats icon
% Masters:
34%
Learn More About Seagen Inc blue arrow
* Ladders Estimates